Welcome to BioReagent Hub Hotline:19920083827

MiR-124-3p Suppresses Prostatic Carcinoma by Targeting PTGS2 Through the AKT/NF-κB Pathway

More in this category

✉Email 💬Message 👤Member
↑Top